Cigna Group (CI) Projected to Post Earnings on Thursday

Cigna Group (NYSE:CI) is expected to be releasing its Q3 2025 results before the market opens on Thursday, October 30th. Analysts expect Cigna Group to post earnings of $7.70 per share and revenue of $66.3954 billion for the quarter. Cigna Group has set its FY 2025 guidance at 29.600- EPS.Investors may visit the the company’s upcoming Q3 2025 earningresults page for the latest details on the call scheduled for Thursday, October 30, 2025 at 8:30 AM ET.

Cigna Group (NYSE:CI) last released its quarterly earnings data on Thursday, July 31st. The health services provider reported $7.20 earnings per share (EPS) for the quarter, topping the consensus estimate of $7.15 by $0.05. Cigna Group had a net margin of 1.92% and a return on equity of 18.80%. The company had revenue of $67.13 billion during the quarter, compared to the consensus estimate of $62.61 billion. During the same period in the previous year, the firm earned $6.72 earnings per share. Cigna Group’s revenue for the quarter was up 11.0% on a year-over-year basis. On average, analysts expect Cigna Group to post $30 EPS for the current fiscal year and $33 EPS for the next fiscal year.

Cigna Group Stock Down 0.0%

Shares of Cigna Group stock opened at $309.10 on Wednesday. The company has a fifty day moving average price of $299.57 and a 200 day moving average price of $307.33. The company has a current ratio of 0.71, a quick ratio of 0.71 and a debt-to-equity ratio of 0.65. Cigna Group has a twelve month low of $256.89 and a twelve month high of $350.00. The stock has a market cap of $82.51 billion, a price-to-earnings ratio of 16.87, a price-to-earnings-growth ratio of 0.91 and a beta of 0.45.

Cigna Group Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Thursday, December 18th. Stockholders of record on Thursday, December 4th will be given a $1.51 dividend. The ex-dividend date of this dividend is Thursday, December 4th. This represents a $6.04 annualized dividend and a dividend yield of 2.0%. Cigna Group’s dividend payout ratio is presently 32.97%.

Analysts Set New Price Targets

A number of research firms have weighed in on CI. Weiss Ratings restated a “hold (c+)” rating on shares of Cigna Group in a report on Wednesday, October 8th. Wells Fargo & Company upped their target price on shares of Cigna Group from $340.00 to $354.00 and gave the company an “equal weight” rating in a research note on Tuesday, October 7th. The Goldman Sachs Group initiated coverage on shares of Cigna Group in a research report on Tuesday, October 14th. They issued a “buy” rating and a $370.00 price objective for the company. Wall Street Zen cut shares of Cigna Group from a “buy” rating to a “hold” rating in a research report on Friday, October 3rd. Finally, Barclays increased their price target on Cigna Group from $354.00 to $383.00 and gave the company an “overweight” rating in a report on Thursday, September 4th. Two investment analysts have rated the stock with a Strong Buy rating, sixteen have given a Buy rating and three have given a Hold rating to the company’s stock. Based on data from MarketBeat, Cigna Group currently has a consensus rating of “Moderate Buy” and a consensus price target of $369.89.

Insider Buying and Selling

In related news, insider Nicole S. Jones sold 28,526 shares of the firm’s stock in a transaction on Friday, August 15th. The stock was sold at an average price of $300.00, for a total transaction of $8,557,800.00. Following the transaction, the insider directly owned 25,648 shares in the company, valued at $7,694,400. This trade represents a 52.66% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, insider Brian C. Evanko sold 5,368 shares of the firm’s stock in a transaction on Friday, October 3rd. The stock was sold at an average price of $300.00, for a total value of $1,610,400.00. Following the transaction, the insider owned 51,182 shares in the company, valued at $15,354,600. This trade represents a 9.49% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Company insiders own 0.70% of the company’s stock.

Institutional Inflows and Outflows

A number of large investors have recently modified their holdings of the business. Brighton Jones LLC lifted its holdings in Cigna Group by 9.3% in the fourth quarter. Brighton Jones LLC now owns 3,736 shares of the health services provider’s stock worth $1,032,000 after acquiring an additional 318 shares during the last quarter. Sivia Capital Partners LLC lifted its stake in Cigna Group by 10.4% in the second quarter. Sivia Capital Partners LLC now owns 1,160 shares of the health services provider’s stock valued at $384,000 after buying an additional 109 shares during the last quarter. NewEdge Advisors LLC lifted its stake in Cigna Group by 4.5% in the second quarter. NewEdge Advisors LLC now owns 22,225 shares of the health services provider’s stock valued at $7,347,000 after buying an additional 958 shares during the last quarter. Treasurer of the State of North Carolina lifted its stake in Cigna Group by 16.6% in the second quarter. Treasurer of the State of North Carolina now owns 148,840 shares of the health services provider’s stock valued at $49,204,000 after buying an additional 21,173 shares during the last quarter. Finally, Osterweis Capital Management Inc. bought a new stake in Cigna Group in the 2nd quarter valued at about $163,000. 86.99% of the stock is currently owned by institutional investors.

About Cigna Group

The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers.